Biểu đồ giá cổ phiếu MLTX
MLTX Thu nhập
MoonLake Immunotherapeutics
$0
0%
$0
Khi đóng cửa: May 13, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: May 13, 18:33:06 GMT-4
Quay lại
MoonLake Immunotherapeutics (MLTX) Thu nhập
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
1.7M
Tỷ suất cổ tức
--
EPS (TTM)
-3.52
Vốn hóa thị trường
--
MLTX là gì?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
